Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SOS Trial
ISRCTN16075091Phase 3Active, not recruiting
- Sponsor
- University Hospitals Birmingham
- Start
- Dec 2019
- Modality
- Small Molecules, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
01
Overview
Phase 3, randomised, open-label trial in traumatic brain injury (TBI) comparing Mannitol arm with Hypertonic saline arm (2 arms). Primary endpoint: Primary neurological outcome at 6 months. Started Dec 2019; status: active, not recruiting.
02
Drugs
Bronchitolhypertonic saline
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on ISRCTN16075091.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN16075091.